Biotalys NV (BR:BTLS) — Market Cap & Net Worth
Market Cap & Net Worth: Biotalys NV (BTLS)
Biotalys NV (BR:BTLS) has a market capitalization of $86.26 Million (€73.78 Million) as of September 18, 2026. Listed on the BR stock exchange, this Belgium-based company holds position #19833 globally and #85 in its home market, demonstrating a -8.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biotalys NV's stock price €1.96 by its total outstanding shares 37568645 (37.57 Million). Also see Biotalys NV (BTLS) total assets for a full breakdown of the balance sheet.
Biotalys NV Market Cap History: 2021 to 2026
Biotalys NV's market capitalization history from 2021 to 2026. Data shows change from $317.99 Million to $86.26 Million (-21.63% CAGR). Also see Biotalys NV cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
Biotalys NV is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BEL Small
BELS
|
$5.84 Billion | 1.48% | #16 of 20 |
|
BEL All Share
BSPT
|
$835.18 Billion | 0.01% | #88 of 108 |
Weight: Biotalys NV's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biotalys NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biotalys NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BTLS stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BTLS by Market Capitalization
Companies near Biotalys NV in the global market cap rankings as of September 18, 2026. Review BTLS tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Biotalys NV by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #541 globally with a market cap of $50.57 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #724 globally with a market cap of $38.16 Billion USD ( CA$52.75 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1327 globally with a market cap of $19.35 Billion USD ( CN¥132.24 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1498 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #541 | Corteva Inc | NYSE:CTVA | $50.57 Billion | $81.53 |
| #724 | Nutrien Ltd | TO:NTR | $38.16 Billion | CA$110.53 |
| #1327 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $19.35 Billion | CN¥24.99 |
| #1498 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $133.82 |
Biotalys NV Historical Marketcap From 2021 to 2026
Between 2021 and today, Biotalys NV's market cap moved from $317.99 Million to $ 86.26 Million, with a yearly change of -21.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €86.26 Million | -41.72% |
| 2025 | €148.02 Million | +2.74% |
| 2024 | €144.06 Million | -29.76% |
| 2023 | €205.11 Million | -31.32% |
| 2022 | €298.67 Million | -6.08% |
| 2021 | €317.99 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Biotalys NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.26 Million USD |
| MoneyControl | $86.26 Million USD |
| MarketWatch | $86.26 Million USD |
| marketcap.company | $86.26 Million USD |
| Reuters | $86.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biotalys NV
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6… Read more